Our Work

We are inspired by companies, researchers and entrepreneurs who want to make a true difference

We work with great clients and great people. Catalyze supports a variety of Life Sciences developments including, but not limited to, diagnostics, pharmaceuticals, medical devices and healthcare solutions. Our clients range from researchers at academic hospitals and universities, to non-profit organizations, start-ups, SMEs and larger companies. This includes clients who focus on their own product development, but also strong partnerships with the services industry like CROs, formulation partners, clinical trials experts and regulatory experts.

View some example cases

 

SkylineDx; novel gene-expression profiling technology

SkylineDx; novel gene-expression profiling technology

SkylineDx has been awarded a multi-million euro Horizon2020 grant from the European Commission to develop a new, and novel gene-expression profiling technology, which is intended to predict the most effective treatment strategy for patients with multiple myeloma (MM).

INCISION Academy next step towards universal surgical language

INCISION Academy next step towards universal surgical language

The SurgASSIST project aims to improve surgical care by changing the way surgeons are educated. The SurgASSIST project provides an online educational program, the INCISION Academy, that uses 3D visualizations (stereoscopic videos and animations) to teach surgical procedures step-by-step, based on state-of-the-art scientific research and best-practice surgical care.

Novel drug delivery method for DR patients

Novel drug delivery method for DR patients

PREVIN combines a novel drug delivery method to treat patients with Diabetic Retinopathy (DR) (i.e. blindness in Diabetes patients) with established drugs.

Perceive 3D presents a new concept of video based intra-operative navigation

Perceive 3D presents a new concept of video based intra-operative navigation

Perceive3D has received a prestigious €1.3 EU million grant from the Horizon 2020 SME Instrument Phase 2 funding to develop in.nav. In.nav is the first system for intra-operative navigation based on video.

ESCAPE-NET project aims to improve SCA management

ESCAPE-NET project aims to improve SCA management

Sudden cardiac arrest (SCA) causes ~20% of all deaths in Europe. SCA is lethal within minutes if left untreated and survival rates are presently only 5-20%. Therefore, there is a large medical need to improve SCA prevention and treatment.

Epithydia proposal ranks 1st out of 300 in Eurostars application

Epithydia proposal ranks 1st out of 300 in Eurostars application

The grant proposal written by Catalyze for the Epithydia project ranked 1st out of 300 applications.

COST Actions for ‘good biomarker practice’

COST Actions for ‘good biomarker practice’

COST funds pan-European, bottom-up networks of scientists and researchers across all science and technology fields. These networks, called ‘COST Actions’, promote international coordination of nationally-funded research.

ICENESS tube solution for cryopreserved biosamples

ICENESS tube solution for cryopreserved biosamples

Freeze-thawing cycles are disastrous for cryopreserved biosamples. The frozen ICENESS tube can be subdivided in to sections to circumvent this problem.

Imaging agent to determine colorectal cancer relapse

Imaging agent to determine colorectal cancer relapse

META-DETECT will develop a multi-target imaging agent to diagnose, stage and determine the risk of relapse in colorectal cancer (CRC).

Novel therapeutic antibody

Novel therapeutic antibody

NOVA-CARE aims to establish preclinical efficacy in mouse and porcine disease models for a novel therapeutic monoclonal antibody (mAb) to prevent non-ischaemic heart failure (NI-HF) by targeting EDA-fibronectin (EDA).